An analysis of more than 3.7 million pregnant women enrolled from 2000 through 2010 in Medicaid found an association between use of selective serotonin reuptake inhibitors and newborns with persistent pulmonary hypertension.
This pragmatic randomized trial compares the effects of a second anti–tumor necrosis factor (TNF) drug vs non–TNF-targeted biologic therapy among patients with rheumatoid arthritis for whom a first anti-TNF drug had failed.
This Special Communication summarizes published evidence about the causes of elevated prescription drug prices in the United States and proposes policy options to mitigate the effects of high prices while preserving incentives for development and innovation.
This Viewpoint describes 6 pilot programs from the Centers for Medicare & Medicaid Services aimed at lowering Part B drug costs by discussing their application to cancer treatments.
This pharmacoepidemiology study uses NHANES data to describe trends in prescription drug use among US adults between 1999 and 2012.
This Viewpoint addresses the benefits and challenges of adopting indication-specific pricing for cancer drugs.
Because 36% of US adults are obese with many unable to lose weight to improve health, Yanovski and Yanovski systematically review medications currently approved for obesity treatment and discuss off-label use of medications studied for obesity and use of obesity medications in clinical practice.
This population epidemiology study uses national survey data to characterize national trends in prescription opioid use and opiod use disorders and related mortality.